R. Lisandro Perez Ferrel, PGY 4 Medical Oncology and Researcher at Complejo Universitario de Canarias, shared a post on LinkedIn:
“I am deeply grateful to the Phase I Clinical Trials Unit at INCLIVA Instituto de Investigación Sanitaria for the opportunity to complete my rotation in such an outstanding environment of early drug development, clinical research, and multidisciplinary collaboration.
This experience represented far more than a training period; it offered valuable insight into innovation-driven medicine, patient-centered research, and the complexity of early-phase clinical trials.
I would like to sincerely thank Prof. andres cervantes Cervantes for accepting and making possible this rotation opportunity, and the Phase I team — Dra. Valentina Gambardella , Dra. Desamparados Roda Perez , and Dr. Victor Seguí — for their guidance, support, and generosity in sharing their expertise. I am also grateful to the research nurses, monitors, and especially the patients, whose commitment and trust are at the heart of clinical research.
This rotation has been both professionally enriching and personally inspiring, reinforcing my interest in clinical research and continuous learning.”
More posts on OncoDaily.
